KTB TUMORFORSCHUNGSGESELLSCHAFT MBH has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, United States and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CARDIOLYNX AG, FOREST LABORATORIES HOLDINGS LTD and PFLEGER R CHEM FAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | United States | 5 | |
#3 | Brazil | 3 | |
#4 | Canada | 3 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Sugars | |
#5 | Peptides | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Kratz Felix | 14 |
#2 | Warnecke Andre | 5 |
#3 | Merfort Irmgard | 4 |
#4 | Felix Kratz | 2 |
#5 | Wolfel Sebastian | 1 |
#6 | Muller Ivonne | 1 |
#7 | Kunick Conrad | 1 |
#8 | Elsadek Bakheet | 1 |
#9 | Totzke Frank | 1 |
#10 | Schachtele Christoph | 1 |
Publication | Filing date | Title |
---|---|---|
US2015023912A1 | Combinations of albumin-based drug delivery systems | |
AU2012219936A1 | Bisphosphonate-prodrugs | |
AU2008214801A1 | Dual acting prodrugs |